About Endospan
Endospan brings together a seasoned team of researchers, engineers and executives in the MedTech field. Backed by leading global venture groups, Endospan is focused on becoming a dominant competitor in the endovascular aortic repair market.The Endospan platform is innovative, opening up options for repairing aneurysms and dissections in patients with anatomy previously unsuitable for endovascular therapy. The novel design of Endospan’s systems presents a true advancement when compared to traditional EVAR/TEVAR systems, enhancing endografts with gold-standard material durability, intra-procedural stability, and a shorter, simpler and less-invasive procedure.
Our Leadership
Kevin Mayberry
Chief Executive Officer
Former Endologix executive with 14 years experience in R&D and global sales management demonstrating technical, sales, and marketing expertise. Innovative leader of R&D teams from concept through CE mark and IDE studies on multiple PMA products.
Ami Katz
Vice President of Operations | General Manager IL
Ami Katz has over 15 years of experience in operation management, production and product management, 7 of which are in the medical field. Prior to Endospan, Ami Katz held several VP of Operations roles and led start up companies from R&D to commercial phases (CE and FDA).
Ian Mcdougall
Vice President | Research and Development
Ian McDougall has over 20 years experience in leading teams that took products from concept, through clinical trial, and market approval in the interventional cardiology, cardiac surgery, and neurovascular fields. Prior to Endospan, Ian held director of engineering and executive roles at Aegis Innovation, Neovasc Inc., and Evasc Medical.
Jessica Kleine
Vice President of Operations of Clinical Affairs
Jessica Kleine has over 19 years of experience developing, delivering, and leading robust clinical and regulatory strategies. She has a proven track record for facilitating timely global approvals for state-of-the-art class III devices. Jessica has been an executive for both medical device start-ups and large strategic organizations, successfully executing clinical and regulatory programs in those roles. She has a real talent for balancing risk while assessing progress and allocating resources based on evolving business needs. One of her major strengths is her passion for identifying unmet clinical needs and then utilizing her clinical and regulatory skills to help bring a medical device to the market to serve the unmet need with the patient at the forefront of her mind.
Gadi Divald
Chief Financial Officer
Gadi Divald has more than 20 years of experience as a finance and business executive, with a proven international track record in early-stage startups and private and public medium size corporates. During his career, Gadi served as CFO at Mul-T-Lock, General Manager at SanDisk Spain (Madrid, Spain), VP of Finance & Operations at msystems Asia (Taipei, Taiwan), and as CFO in other early-stage and VC backed startups (3d Signals, Upright Technologies, c2 microsystems and more). Gadi is a Certified Public Accountant (CPA) and holds a BA in accounting and business administration.
Carlos Camps
Vice President of Global Marketing
Experienced Global Marketing Executive with demonstrated history of success at a Global level on Class III devices by delivering business development through the management of high performing teams with a laser focus customer orientation and results driven. Professional graduated from ESADE and Babson College - Franklin W. Olin Graduate School of Business.
Antonio Gonzalez de Jesus
Vice President of Sales EMEA LatAm
Tony González has over 28 years of experience in the endovascular field, mainly in abdominal, thoracic, thoraco abdominal and arch procedures. Tony gained experience in the early days as an aortic clinical specialist with companies such as Boston Scientific (Vascular Division) and Medtronic Aortic, successfully launching its Endovascular products. Tony’s role evolved into General Manager role in Jotec and Cryolife.
Our medical directors
Mario Lachat
Medical Director, NEXUS
Mario Lachat is early adopter of the Horizon and Nexus Stentgraft systems (since 2013). As cardiovascular surgeon and expert in complex open surgery and endoaortic procedures he published over 300 relevant papers. He conducted several national and international studies. He is experienced in team training and proctoring new technologies.